191 related articles for article (PubMed ID: 27861771)
1. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
[TBL] [Abstract][Full Text] [Related]
2. Familial hypercholesterolaemia: cholesterol efflux and coronary disease.
Versmissen J; Vongpromek R; Yahya R; van der Net JB; van Vark-van der Zee L; Blommesteijn-Touw J; Wattimena D; Rietveld T; Pullinger CR; Christoffersen C; Dahlbäck B; Kane JP; Mulder M; Sijbrands EJ
Eur J Clin Invest; 2016 Jul; 46(7):643-50. PubMed ID: 27208892
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
[TBL] [Abstract][Full Text] [Related]
4. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
Therond P; Chapman MJ
Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
[TBL] [Abstract][Full Text] [Related]
7. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.
Tao R; Hoover HE; Honbo N; Kalinowski M; Alano CC; Karliner JS; Raffai R
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1022-8. PubMed ID: 20061542
[TBL] [Abstract][Full Text] [Related]
9. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
[TBL] [Abstract][Full Text] [Related]
10. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
11. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate.
Sato K; Malchinkhuu E; Horiuchi Y; Mogi C; Tomura H; Tosaka M; Yoshimoto Y; Kuwabara A; Okajima F
Biochem Biophys Res Commun; 2007 Aug; 359(3):649-54. PubMed ID: 17544365
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatment.
Brulhart-Meynet MC; Thomas A; Sidibé J; Visentin F; Dusaulcy R; Schwitzgebel V; Pataky Z; Philippe J; Vuilleumier N; James RW; Gosmain Y; Frias MA
Physiol Rep; 2021 Mar; 9(6):e14786. PubMed ID: 33769715
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
[TBL] [Abstract][Full Text] [Related]
15. Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases.
Diarte-Añazco EMG; Méndez-Lara KA; Pérez A; Alonso N; Blanco-Vaca F; Julve J
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842389
[TBL] [Abstract][Full Text] [Related]
16. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate.
Bode C; Sensken SC; Peest U; Beutel G; Thol F; Levkau B; Li Z; Bittman R; Huang T; Tölle M; van der Giet M; Gräler MH
J Cell Biochem; 2010 Apr; 109(6):1232-43. PubMed ID: 20186882
[TBL] [Abstract][Full Text] [Related]
18. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.
Brulhart-Meynet MC; Braunersreuther V; Brinck J; Montecucco F; Prost JC; Thomas A; Galan K; Pelli G; Pedretti S; Vuilleumier N; Mach F; Lecour S; James RW; Frias MA
PLoS One; 2015; 10(3):e0119664. PubMed ID: 25781943
[TBL] [Abstract][Full Text] [Related]
19. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
Frias MA; Lang U; Gerber-Wicht C; James RW
Cardiovasc Res; 2010 Jan; 85(1):118-26. PubMed ID: 19700468
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]